Truist Securities models $730M peak revenue for Protagonist Therapeutics (PTGX) in Icotyde royalties

Go back to Truist Securities models $730M peak revenue for Protagonist Therapeutics (PTGX) in Icotyde royalties
(NASDAQ: PTGX) Delayed: 95.41 +2.18 (2.34%)
Previous Close $93.23    52 Week High $24.52 
Open $93.93    52 Week Low $10.02 
Day High $95.61    P/E N/A 
Day Low $93.00    EPS $0.00 
Volume 579,220